Orally administered HY7801 regulates immune biomarkers, including TNF-α, IFN-γ, IL-17A, IL-10, and IL-12, and might be useful in the treatment of rheumatoid arthritis [41]. Here, IL17A is linked to rheumatoid arthritis.